Clinical Trials
8
Active:0
Completed:7
Trial Phases
2 Phases
Phase 1:6
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)β’ Click on a phase to view related trials
Phase 1
6 (75.0%)Phase 2
2 (25.0%)A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy Participants
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- Taisho Pharmaceutical R&D Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT04464239
- Locations
- πΊπΈ
PPD Phase I unit, Austin, Texas, United States
First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants
- First Posted Date
- 2019-04-18
- Last Posted Date
- 2020-02-28
- Lead Sponsor
- Taisho Pharmaceutical R&D Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT03919409
- Locations
- πΊπΈ
PAREXEL - Early Phase Clinical Unit-Los Angeles, Glendale, California, United States
Safety, Tolerability and Pharmacokinetics of Single Doses of TS-134 in Healthy Volunteers
- First Posted Date
- 2018-11-19
- Last Posted Date
- 2018-11-19
- Lead Sponsor
- Taisho Pharmaceutical R&D Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT03746067
- Locations
- πΊπΈ
PAREXEL - Early Phase Clinical Unit-Los Angeles, Glendale, California, United States
Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy Volunteers
- First Posted Date
- 2018-11-15
- Last Posted Date
- 2018-11-15
- Lead Sponsor
- Taisho Pharmaceutical R&D Inc.
- Target Recruit Count
- 59
- Registration Number
- NCT03742791
- Locations
- πΊπΈ
PAREXEL - Early Phase Clinical Unit-Los Angeles, Glendale, California, United States
Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects
- First Posted Date
- 2017-05-05
- Last Posted Date
- 2018-04-30
- Lead Sponsor
- Taisho Pharmaceutical R&D Inc.
- Target Recruit Count
- 63
- Registration Number
- NCT03141658
- Locations
- πΊπΈ
New York State Psychiatric Institute, New York, New York, United States
- Prev
- 1
- 2
- Next
News
No news found